Leonteq Securities AG’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Leonteq Securities AG's CRL Position: Q4 2025 in Review
Leonteq Securities AG sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 3,202 shares — an estimated $501K sold.
Leonteq Securities AG first reported a position in CRL in Q4 2020 and held it in 17 quarters. The position peaked at $893K in Q3 2021. 582 funds tracked by Wall St. Rank hold CRL as of Q4 2025.
- Leonteq Securities AG reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
- Leonteq Securities AG sold 3,202 Charles River Laboratories shares in Q4 2025, an estimated $501K.
- Leonteq Securities AG first reported a position in Charles River Laboratories in Q4 2020 and held it in 17 quarters.
- Leonteq Securities AG's Charles River Laboratories position peaked at $893K in Q3 2021.
- 582 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.
Based on Leonteq Securities AG's 13F filing for Q4 2025, filed 6 Feb 2026.